Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Adeptus Health Reports Second Quarter 2016 Results

      Net Operating Revenue Increased 12% for Second Quarter

      Systemwide Revenue Increased 36% for Second Quarter

      Adjusted EBITDA Decreased 2% for Second Quarter

      EPS Increased to $5.80

      Adjusted EPS Increased to $0.48


      News provided by

      Adeptus Health Inc.

      Jul 21, 2016, 06:50 ET

      Share this article

      Share this article


      LEWISVILLE, Texas, July 21, 2016 /PRNewswire/ -- Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company"), the largest operator of freestanding emergency rooms in the U.S., announced its results for the second quarter ended June 30, 2016. All comparisons included in this release are for the same period in the prior year, unless otherwise noted. See "Non-GAAP Financial Measures Description and Reconciliation" for further information related to systemwide revenue, Adjusted EBITDA and Adjusted earnings per share.

      Second Quarter 2016 Highlights:

      Adeptus Health, Inc.
      Adeptus Health, Inc.
      • Net operating revenue was $100.2 million versus $89.6 million in prior year, an increase of 12%;
      • Systemwide net patient services revenue was $142.4 million versus $104.5 million in prior year, an increase of 36%;
      • Adjusted EBITDA was $22.5 million versus $22.9 million in prior year, a decrease of 2%;
      • Net income attributable to Adeptus Health Inc. was $86.9 million versus $10.6 million in prior year;
      • GAAP earnings per share was $5.80 and Adjusted earnings per share was $0.48;
      • A gain of $185.3 million was recognized as a result of the joint venture with Texas Health Resources, one of the country's largest non-profit health systems;
      • Cash flow used in operating activities was $8.6 million versus $13.0 million provided by operating activities in prior year, and;
      • Systemwide same store volumes increased 4.3% and systemwide same store revenue decreased 2.8% versus prior year.

      2016 Guidance Reaffirmed

      We continue to expect systemwide net patient services revenue, which includes revenue from our unconsolidated joint ventures, of $640.0 million to $670.0 million for the full year 2016. We expect Adjusted EBITDA of $110.0 million to $115.0 million and Adjusted earnings per share of $2.55 to $2.65 for the full year 2016.

      Results of Operations for the Second Quarter 2016

      Thomas S. Hall, Chairman and CEO, stated, "Second quarter results were in-line with the preview we provided in late May, despite unexpected softer volumes in June. The volume weakness was primarily in markets where our facilities are not operated as hospital outpatient departments (HOPDs). We continue to execute on our HOPD strategy which is delivering positive same store results in the Dallas/Fort Worth market. We anticipate similar increases in patient volume with the upcoming HOPD conversions in Denver, Colorado Springs and Houston as the hospitals in those markets open later this year."

      Hall continued, "In May, we announced a landmark joint venture with Texas Health Resources ("THR"), one of the country's largest non-profit health systems, and all of our facilities in the Dallas/Fort Worth market will be rebranded as Texas Health before year end. As a direct result of the joint venture, we recognized a $185.3 million gain on our contribution based upon a third party valuation which further validates our business model."

      For the second quarter of 2016, ADPT generated total net operating revenue of $100.2 million, an increase of 12%. From inception of each joint venture, net operating revenue excludes revenue from unconsolidated facilities. Net operating revenue excludes revenue from the 16 Colorado freestanding facilities, the Arizona hospital and its seven freestanding facilities, and the Dallas/Fort Worth hospital and its 30 freestanding facilities, which are accounted for as equity method investments. The increase was primarily attributable to increases in management fees and contract services revenue, the impact of patient volumes from both existing and new consolidated freestanding facilities and annual gross charge increases, offset by the deconsolidation of our Colorado and Dallas/Fort Worth locations due to the UCHealth and THR joint ventures. Through June 30, 2016, ADPT has opened 12 new freestanding emergency facilities in 2016.

      ADPT generated net income of $148.2 million for the quarter, of which $86.9 million was attributable to Adeptus Health Inc., compared to net income of $27.7 million from the prior year, of which $10.6 million was attributable to Adeptus Health Inc. The increase in net income was due to an increase of $10.6 million in net operating revenue, a $2.1 million decrease in interest expense, and a $185.3 million gain recognized on the contribution and change of control of previously owned facilities to the joint venture with THR. This increase was partially offset by a $1.2 million decrease in equity in earnings of unconsolidated joint ventures, an increase of salaries, wages, and benefits and other costs related to our growth initiatives and the impact of deferred taxes associated with the gain recognized on the contribution and change of control of previously owned facilities to the joint venture with THR.

      Adjusted EBITDA was $22.5 million for the quarter compared to $22.9 million in prior year. This decrease was attributable to a $1.2 million decrease in equity in earnings of unconsolidated joint ventures and an increase of salaries, wages, and benefits and other costs related to our growth initiatives, offset by increases in management and contract services revenue. See "Non-GAAP Financial Measures Description and Reconciliation" and "Reconciliation of Adjusted EBITDA to Net Income" below for further information related to Adjusted EBITDA and its reconciliation to net income.

      GAAP earnings per share was $5.80 per share and Adjusted earnings per share was $0.48 per share for the quarter. Adjusted earnings per share is calculated using a weighted average of both Class A and Class B common shares outstanding, which was an aggregate of 21,076,911 common shares at June 30, 2016. See "Non-GAAP Financial Measures Description and Reconciliation" and "Earnings Per Share Reconciliation" below for further information related to Adjusted earnings per share and its reconciliation to net income.

      Systemwide Financial Results

      For the second quarter of 2016, ADPT generated systemwide net patient services revenue of $142.4 million, an increase of 36%. Additionally, systemwide same store volumes increased 4.3% versus prior year and systemwide same store revenue decreased 2.8%. Systemwide same store volume growth was driven by the Dallas/Fort Worth facilities. The decline in systemwide same store revenues reflected softer volumes in non-HOPD markets in June. The increase in systemwide net patient services revenue was primarily attributable to the impact of increased patient volumes from the expansion of the number of freestanding facilities from 68 to 93, annual gross charge increases, and continued growth of our hospitals and their hospital outpatient departments in Arizona and Texas.

      As of June 30, 2016, our 16 Colorado freestanding facilities associated with our joint venture with UCHealth, our Arizona hospital and its seven freestanding facilities associated with our joint venture with Dignity Health and our Dallas Fort Worth hospital and its 30 freestanding facilities associated with our joint venture with THR were accounted for using the equity method. For consolidated subsidiaries, the Company's financial statements reflect 100% of the revenues and expenses for these subsidiaries, after elimination of intercompany transactions and accounts. For our unconsolidated joint ventures, consolidated statements of operations reflect those earnings in two line items:

      • Equity in earnings of unconsolidated joint ventures, which represents our share of the net income or loss of each equity method joint venture based on our ownership percentage; and
      • Management and contract services revenues, which represent the Company's combined income from management and contract services that are earned from managing the day-to-day operations and providing contract staffing of the facility.

      As a result of this accounting treatment in our reported results, management supplementally focuses on non-GAAP systemwide metrics to analyze the results of operations. These systemwide metrics include systemwide net patient services revenue. Systemwide metrics treat our unconsolidated facilities as if they were consolidated. While the revenues earned at the unconsolidated facilities are not recorded in our consolidated financial statements, management believes systemwide net patient services revenue growth is important to understand the Company's financial performance because it is used to interpret the sources of our growth and provide a growth metric incorporating the revenues earned by all affiliated facilities, regardless of the accounting treatment. As we execute on our strategy of partnering with health systems, management expects the number of our facilities accounted for under the equity method to increase relative to the total number of affiliated facilities.

      Liquidity

      At the end of the second quarter, the Company had cash of $3.7 million and $23.8 million available under its revolving credit facility.  Net cash flow used in operations was $8.6 million for the second quarter compared to $13.0 million net cash flow provided by operations in the prior year. At June 30, 2016, the Company had total long-term debt and capital lease obligations of $137.6 million and debt net of cash of $133.8 million.

      Market Outlook

      The Company remains on track to open 27 new facilities in 2016, including both owned and joint venture facilities. These include 24 new freestanding facility openings and three new hospitals – two in Colorado and one in Houston, Texas.

      "Through the expansion of our network of hospitals, freestanding emergency rooms and partnerships with leading health systems, we are continuing to transform the delivery of emergency care in the U.S.," added Hall. "Partnerships remain a cornerstone of our growth strategy. We have a healthy pipeline of partnership opportunities and look forward to announcing additional partnerships as the year progresses." 

      Conference Call

      A live audio webcast to present the second quarter 2016 results will take place today at 11:00 am (Eastern Time), hosted by Thomas S. Hall, Chairman and CEO, Timothy Fielding, CFO, and Graham Cherrington, President and COO.

      The audio webcast will be available by accessing:  https://www.webcaster4.com/Webcast/Page/1069/15975

      Following the call, an archived recording of the replay will also be available on the Adeptus Health Investor Relations page for 30 days: http://ir.adeptushealth.com/events-and-presentations/events/default.aspx

      About Adeptus Health Inc.

      Adeptus Health (NYSE:ADPT) is a leading patient-centered healthcare organization expanding access to the highest quality emergency medical care through its network of freestanding emergency rooms and partnerships with premier healthcare providers. Adeptus Health owns and operates First Choice Emergency Room, the nation's largest and oldest network of freestanding emergency rooms and owns and/or operates hospitals and freestanding facilities in partnership with Texas Health Resources in Texas, UCHealth in Colorado, Dignity Health in Arizona, Ochsner Health System in Louisiana and Mount Carmel Health System in Ohio. All Adeptus Health freestanding facilities are fully equipped emergency rooms with a complete radiology suite of diagnostic technology, on-site laboratory, and staffed with board-certified physicians and emergency trained registered nurses. For the last three years, Adeptus Health has exceeded the 95th percentile in patient satisfaction according to patient feedback collected nationwide by Press Ganey Associates Inc. Adeptus Health also was named a 2016 Best Workplaces in Healthcare by Great Place to Work® and Fortune Magazine. For more information please visit adhc.com.

      Media
      Contact:

      Jackie Zupsic

      Hill & Knowlton Strategies

      [email protected]

      Tel: (212) 885 – 0590



      Investor
      Relations
      Contact:

      Kevin Ellich

      Vice President, Investor Relations

      [email protected]

      Tel: (972) 899-7062

      Forward-Looking Statements

      Certain statements and information herein may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our guidance, objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Any forward-looking statements herein are made as of the date of this press release, and ADPT undertakes no duty to update or revise any such statements except as required by the federal securities laws. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in ADPT's filings with the U.S. Securities and Exchange Commission ("SEC") from time to time and which are accessible on the SEC's website at www.sec.gov, including in the section entitled "Risk Factors" in the Company's Form 10-K for the fiscal year ended December 31, 2015. Among the factors that could cause future results to differ materially from those provided in this press release are: our ability to implement our growth strategy; our ability to maintain sufficient levels of cash flow to meet growth expectations; our ability to protect our brand; federal and state laws and regulations relating to our facilities, which could lead to the incurrence of significant penalties by us or require us to make significant changes to our operations; our ability to locate available facility sites on terms acceptable to us; competition from hospitals, clinics and other emergency care providers; our dependence on payments from third-party payors; our ability to source and procure new products and equipment to meet patient preferences; our reliance on Medical Properties Trust ("MPT") and the MPT Master Funding and Development Agreements; disruptions in the global financial markets leading to difficulty in borrowing sufficient amounts of capital to finance the carrying costs of inventory to pay for capital expenditures and operating costs; our ability or the ability of our healthcare system partners to negotiate favorable contracts or renew existing contracts with third-party payors on favorable terms; significant changes in our payor mix or case mix resulting from fluctuations in the types of cases treated at our facilities; significant changes in the rules, regulations and systems governing Medicare and Medicaid reimbursements; material changes in IRS revenue rulings, case law or the interpretation of such rulings; shortages of, or quality control issues with, emergency care-related products, equipment and medical supplies that could result in a disruption of our operations; the intense competition we face for patients, physician use of our facilities, strategic relationships and commercial payor contracts; the fact that we are subject to significant malpractice and related legal claims; the growth of patient receivables or the deterioration in the ability to collect on those accounts; the impact on us of PPACA, which represents a significant change to the healthcare industry; and ensuring our continued compliance with HIPAA, which could require us to expend significant resources and capital; and the factors discussed in the section entitled "Risk Factors" in the Company's Form 10-K for the fiscal year ended December 31, 2015.

      Non-GAAP Financial Measures Description and Reconciliation

      This press release includes presentations of Adjusted EBITDA, which is defined as net income before interest, taxes, depreciation and amortization, further adjusted to eliminate the impact of certain additional items, including, facility preopening expenses, stock compensation expense and other non-recurring costs, losses or gains.

      This press release also includes presentation of Adjusted earnings per share, which is defined as earnings per share related to the Company's overall operation, including controlling and non-controlling interests, as adjusted to exclude certain additional items, including, facility preopening expenses, stock compensation expense and other non-recurring costs, losses or gains and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes, divided by the aggregate number of shares of Class A and Class B common stock outstanding as of the end of the period.

      In addition, this press release presents systemwide metrics to analyze the results of operations. These systemwide metrics include systemwide net patient services revenue. Systemwide metrics treat our unconsolidated facilities as if they were consolidated.

      These non-GAAP financial measures, Adjusted EBITDA, Adjusted earnings per share and systemwide metrics, are commonly used by management and investors as performance measures. The Company's non-GAAP financial measures are not considered measures of financial performance under U.S. generally accepted accounting principles (GAAP), and the items excluded therefrom are significant components in understanding and assessing our financial performance. These non-GAAP financial measures should not be considered in isolation or as an alternative to GAAP measures such as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance. Reconciliations of non-GAAP financial measures are provided in this press release.  Since these non-GAAP financial measures are not measures determined in accordance with GAAP and are susceptible to varying calculations, these measures, as presented, may not be comparable to other similarly titled measures of other companies.

      Adeptus Health Inc.

      Condensed Consolidated Statements of Income and Other Information

      (unaudited; in thousands, except shares, per share data and other information) 










      Three months ended 


      Six months ended


      June 30,


      June 30,


      2016


      2015


      2016


      2015









      Patient service revenue

      $ 101,595


      $ 104,363


      $ 234,883


      $ 200,265

      Provision for bad debt

      (16,673)


      (17,514)


      (43,726)


      (32,459)

      Net patient service revenue

      84,922


      86,849


      191,157


      167,806

      Management and contract services revenue

      15,245


      2,738


      21,779


      3,234

      Total net operating revenue

      100,167


      89,587


      212,936


      171,040

      Equity in earnings of unconsolidated joint ventures

      2,435


      3,621


      4,936


      2,927

      Operating expenses:








      Salaries, wages and benefits

      62,130


      51,124


      128,945


      100,004

      General and administrative

      13,015


      11,370


      29,279


      21,834

      Other operating expenses

      12,093


      12,541


      27,106


      23,846

      Depreciation and amortization

      3,412


      4,523


      7,783


      9,279

      Total operating expenses

      90,650


      79,558


      193,113


      154,963

      Income from operations

      11,952


      13,650


      24,759


      19,004

      Other income (expense):








      Gain on contribution to joint venture

      185,336


      24,250


      185,336


      24,250

      Interest expense

      (1,822)


      (3,898)


      (3,648)


      (7,172)

      Total other income

      183,514


      20,352


      181,688


      17,078

      Income before provision for income taxes

      195,466


      34,002


      206,447


      36,082

      Provision for income taxes

      47,270


      6,328


      50,388


      6,806

      Net income

      148,196


      27,674


      156,059


      29,276

      Less: Net income attributable to the non-controlling interest

      61,248


      17,040


      64,579


      18,048

      Net income attributable to Adeptus Health Inc. 

      $ 86,948


      $ 10,634


      $ 91,480


      $ 11,228

      Net income per share of Class A common stock:








      Basic

      $ 5.80


      $ 0.97


      $ 6.23


      $ 1.08

      Diluted

      $ 5.80


      $ 0.97


      $ 6.23


      $ 1.08

      Weighted average shares of Class A common stock:








      Basic

      15,001,701


      10,953,138


      14,687,700


      10,432,882

      Diluted

      15,001,701


      10,953,138


      14,687,700


      10,432,882









      Other information








      Consolidated facilities

      40


      54


      40


      54

      Equity method facilities

      55


      15


      55


      15

      Total systemwide facilities, including hospitals

      95


      69


      95


      69

      Adeptus Health Inc.

      Reconciliation of Adjusted EBITDA to Net Income

      (unaudited; in thousands)







      Three months ended 

      Six months ended


      June 30,

      June 30,


      2016

      2015

      2016

      2015






      Net income

      $ 148,196

      $ 27,674

      $ 156,059

      $ 29,276

      Depreciation and amortization(1)

      5,206

      4,929

      10,015

      9,685

      Interest expense

      1,822

      3,898

      3,648

      7,172

      Provision for income taxes

      47,270

      6,328

      50,388

      6,806

      Gain on contribution to joint venture

      (185,336)

      (24,250)

      (185,336)

      (24,250)

      Preopening expenses

      3,294

      1,991

      5,234

      4,089

      Stock compensation expense

      1,221

      608

      2,309

      1,157

      Public offering expenses

      530

      993

      530

      993

      Duplicative billing effort

      -

      -

      208

      -

      Other

      292

      769

      1,179

      1,275

      Total adjustments

      (125,701)

      (4,734)

      (111,825)

      6,927

      Adjusted EBITDA

      $ 22,495

      $ 22,940

      $ 44,234

      $ 36,203


      (1) Includes the Company's proportionate share of depreciation and amortization related to its joint ventures

      Adjusted Earnings Per Share Reconciliation

       (unaudited; in thousands, except shares, per share data and other information)







      Three months ended 

      Six months ended


      June 30,

      June 30,


      2016

      2015

      2016

      2015

      Weighted average common shares outstanding





             Class A common shares

      14,373,699

      10,953,138

      14,687,700

      10,432,882

             Class B common shares

      6,703,212

      9,812,956

      6,292,694

      10,294,067

      Total Class A and B common shares

      21,076,911

      20,766,094

      20,980,394

      20,726,949






      Net income attributable to Adeptus Health Inc.

      $ 86,948

      $ 10,634

      $ 91,480

      $ 11,228

      Net income attributable to non-controlling interest

      61,248

      17,040

      64,579

      18,048

      Total net income

      148,196

      27,674

      156,059

      29,276






      Adjustments:





        Gain on contribution to joint venture

      (185,336)

      (24,250)

      (185,336)

      (24,250)

        Preopening expenses

      3,294

      1,991

      5,234

      4,089

        Stock compensation expense

      1,221

      608

      2,309

      1,157

        Public offering costs

      530

      993

      530

      993

        Duplicative billing effort

      -

      -

      208

      -

        Other

      292

      769

      1,179

      1,275

        Total adjustments

      (179,999)

      (19,889)

      (175,876)

      (16,736)

        Tax impact of adjustments (1)

      63,000

      6,961

      61,557

      5,858

        Tax adjustment resulting from applying effective tax rate (2)

      (21,143)

      (5,573)

      (21,868)

      (5,823)

      Adjusted net income

      10,054

      9,173

      19,872

      12,575

      Adjusted net income per share

      $ 0.48

      $ 0.44

      $ 0.95

      $ 0.61








      (1) Reflects the removal of the tax benefit associated with the adjustments


      (2) Represents adjusting to a normalized effective tax rate of 35%


      Adeptus Health Inc.

      Systemwide Net Patient Services Revenue

      (unaudited; in thousands)
















      Three months ended 


      Six months ended



      June 30,


      June 30,



      2016


      2015


      2016


      2015

      Net Patient Services Revenue:













      Consolidated facilities


      $

      84,922


      $

      86,849


      $

      191,157


      $

      167,806

      Unconsolidated joint ventures



      57,455



      17,659



      91,580



      20,662

      Systemwide net patient services revenue


      $

      142,377


      $

      104,508


      $

      282,737


      $

      188,468

      Adeptus Health Inc.

      Condensed Consolidated Balance Sheets

      (in thousands)






      June 30,


      December 31,


      2016


      2015

      ASSETS

      (unaudited)


      (audited)

      Current assets




      Cash

      $ 3,718


      $ 16,037

      Accounts receivable, less allowance for doubtful accounts of $28,901 and $28,818, respectively

      74,327


      65,954

      Other receivables and current assets

      57,352


      31,532

      Medical supplies inventory

      2,900


      5,167

      Total current assets

      138,297


      118,690

      Property and equipment, net

      34,486


      70,187

      Investment in unconsolidated joint ventures

      272,967


      43,104

      Deposits

      939


      1,163

      Deferred tax asset

      255,886


      206,265

      Intangibles, net

      17,345


      18,235

      Goodwill

      51,390


      61,009

      Other long term assets

      2,046


      2,950

      Total assets

      $ 773,356


      $ 521,603





      LIABILITIES AND SHAREHOLDERS' EQUITY




      Current liabilities




      Accounts payable and accrued expenses

      $ 24,608


      $ 27,521

      Accrued compensation

      17,043


      23,197

      Current maturities of long-term debt

      7,278


      7,585

      Current maturities of capital lease obligations

      40


      102

      Deferred rent

      691


      858

      Total current liabilities

      49,660


      59,263

      Long-term debt, less current maturities

      126,772


      113,563

      Payable to related parties pursuant to tax receivable agreement

      237,914


      191,302

      Capital lease obligation, less current maturities

      177


      3,954

      Deferred rent

      2,453


      3,837

      Total liabilities

      416,976


      371,919

      Commitments and contingencies




      Shareholders' equity




      Preferred stock, par value $0.01 per share; 10,000,000 shares authorized and zero shares issued and outstanding at June 30, 2016

      -


      -

      Class A common stock, par value $0.01 per share; 50,000,000 shares authorized, 16,350,866 and 14,257,187 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively

      164


      143

      Class B common stock, par value $0.01 per share; 20,000,000 shares authorized, 4,724,430 and 6,510,738 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively

      47


      65

      Additional paid in capital

      172,370


      85,457

      Retained earnings

      95,084


      6,323

      Non-controlling interest

      88,715


      57,696

      Total equity

      356,380


      149,684

      Total liabilities and shareholders' equity

      $ 773,356


      $ 521,603

      Adeptus Health Inc.

      Condensed Consolidated Statements of Cash Flows

      (unaudited; in thousands)










      Three months ended 


      Six months ended



      June 30,


      June 30,



      2016

      2015


      2016

      2015

      Cash flows from operating activities:







      Net income


      $ 148,196

      $ 27,674


      $ 156,059

      $ 29,276

      Adjustments to reconcile net income to net cash (used in) provided by operating activities:







           Loss from the disposal or impairment of assets


      -

      68


      2

      68

           Depreciation and amortization


      3,412

      4,523


      7,783

      9,279

           Deferred tax expense


      46,589

      4,122


      48,363

      4,377

           Amortization of deferred loan costs


      194

      249


      387

      468

           Provision for bad debts


      16,673

      17,514


      43,726

      32,459

           Gain on contribution to unconsolidated joint ventures


      (185,336)

      (24,250)


      (185,336)

      (24,250)

           Equity in earnings of unconsolidated joint ventures


      (2,435)

      (3,621)


      (4,936)

      (2,927)

           Stock-based compensation


      1,221

      608


      2,309

      1,157

           Changes in operating assets and liabilities:







              Restricted cash


      -

      64


      -

      (3,009)

              Accounts receivable


      (13,603)

      (14,475)


      (52,099)

      (41,375)

              Other receivables and current assets


      (18,888)

      (2,060)


      (25,996)

      (951)

              Medical supplies inventory


      (20)

      (34)


      (526)

      (160)

              Other long-term assets


      78

      (127)


      261

      (110)

              Accounts payable and accrued expenses


      (3,105)

      2,864


      (1,834)

      (4,140)

              Accrued compensation


      (2,025)

      (1,007)


      (5,085)

      (464)

              Deferred rent


      473

      924


      929

      1,377

          Net cash (used in) provided by operating activities


      (8,576)

      13,036


      (15,993)

      1,075

      Cash flows from investing activities:







      Deposits


      71

      310


      224

      985

      Investments in unconsolidated joint ventures


      (927)

      -


      (927)

      -

      Proceeds from the sale of property and equipment


      -

      10


      -

      1,527

      Capital expenditures


      (1,674)

      (1,650)


      (3,718)

      (3,270)

                Net cash used in investing activities


      (2,530)

      (1,330)


      (4,421)

      (758)

      Cash flows from financing activities:







      Proceeds from public offerings, net of underwriters fees and expenses


      107,389

      94,470


      107,389

      94,470

      Purchase of limited liability units from LLC Unit holders


      (107,389)

      (94,470)


      (107,389)

      (94,470)

      Proceeds from long-term borrowings


      21,000

      30,000


      35,000

      54,000

      Payment of deferred loan costs


      -

      (415)


      -

      (495)

      Payments on borrowings


      (7,013)

      (6,049)


      (23,303)

      (6,691)

      Payments of capital lease obligations


      (11)

      (20)


      (35)

      (39)

      Restricted stock forfeited on vesting to satisfy withholding requirements


      (260)

      -


      (847)

      -

      Tax distribution to unit holders


      (2,548)

      (2,965)


      (2,720)

      (2,965)

                Net cash provided by financing activities


      11,168

      20,551


      8,095

      43,810

      Net increase (decrease) in cash and cash equivalents


      62

      32,257


      (12,319)

      44,127

      Cash, beginning of period


      3,656

      13,872


      16,037

      2,002

      Cash, end of period


      $ 3,718

      $ 46,129


      $ 3,718

      $ 46,129

      Logo - http://photos.prnewswire.com/prnh/20140625/121364

      SOURCE Adeptus Health Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.